期刊文献+

胰腺神经内分泌肿瘤88例临床分析 被引量:12

Pancreatic neuroendocrine tumors: an analysis of 88 patients
原文传递
导出
摘要 目的探讨胰腺神经内分泌肿瘤(PanNETs)的临床病理特点、诊断、治疗以及预后。方法回顾性分析88例PanNETs患者的临床资料,包括年龄、性别、症状、肿瘤大小、病理诊断、TNM分期、治疗以及随访情况,并探讨与预后相关的因素。结果88例患者中,男性28例,女性60例,男女之比1:2.1,年龄8~75岁,平均42岁。88例中无功能型74例(84.1%),功能型14例(15.9%)。根据AJCC7版TNM分期标准,本组88例中I期23例(26.1%),Ⅱ期46例(52.3%),Ⅲ期13例(14.8%),Ⅳ期6例(6.8%)。依据WHO2000年病理分类标准,高分化神经内分泌肿瘤35例(39.8%),高分化神经内分泌癌29例(33.0%),低分化神经内分泌癌24例(27.2%)。33例检测嗜铬粒蛋白A的患者中,27例(81.8%)阳性表达,41例检测突触素的患者中,38例(92.7%)阳性表达。全组患者5年总体生存率为72.0Vo。单因素分析显示肿瘤大小、AJCCTNM分期、病理分类、是否行根治性手术与预后相关。多因素分析显示TNM分期、病理分类以及是否行根治性手术是该组病例的独立预后影响因素。结论PanNETs是一类低度恶性的异质性罕见肿瘤。其临床表现多样,术前误诊率高,确诊依赖病理。新版TNM分期及病理分类能积极指导预后评价。患者经积极手术或以手术为主的综合治疗可获得较好的预后。 Objective To analyze the clinicopathological characteristics, diagnosis, treatment outcomes and prognosis of patients with pancreatic neuroendocrine tumors (PanNETs). Methods The clinicopathological characteristcs and prognostic factors of 88 patients who were diagnosed with pancreatic neuroendocrine tumors by postoperative pathology were analyzed retrospectively. The data included age, sex, symptoms, tumor size, pathological grades, TNM staging, treatment and follow up. Results There were 28 males and 60 females. The ratio of male to female was 1 : 2.1, with a mean age of 42 (range 8-75) years. Of the 88 PanNETs, 74(84.1%) were nonfunctional tumors. Using the WHO 2000 pathological classification system, there were 35 well differentiated endocrine tumors (WDET), 29 well differentiated endocrine carcinomas (WDEC), and 24 poorly differentiated endocrine carcinomas (PDEC). Using the 7th AJCC TNM staging system, 23(26.1%), 46 (52.3%), 13(14.8%) and 6 patients (6.8%) were diagnosed to have stage Ⅰ , Ⅱ, Ⅲ and Ⅳ, respectively. The overall 5-year survival rate was 72.0 %. Univariable analysis revealed tumor size, histopathological grades, TNM staging and radical surgery were associated with prognosis. Multivariate analysis showed histopathological grades, TNM staging and radical surgery were independent risk factors of survival. Conclusions PanNETs are rare pancreatic neoplasms with high heterogeneity and low malig- nant potential. PanNETs have various clinical manifestations and the preoperative misdiagnosis rate is high. A definitive diagnosis depends on pathological examination. The new TNM and pathological classification systems have good predictive abilities on survival. The majority of patients who received radical surgery or surgical comprehensive therapy have good prognosis.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2013年第10期730-733,共4页 Chinese Journal of Hepatobiliary Surgery
关键词 胰腺肿瘤 诊断 治疗 预后 Pancreatic neoplasms Diagnosis Therapy Prognosis
  • 相关文献

参考文献22

  • 1YaoJC, Hassan M, Phan A, et al. One hundred years after" carcinoid": epidemiology of and prognostic factors for neuroen?docrine tumors in 35,825 cases in the United States[J].J Clin Oncol, 2008,26: 3063-3072.
  • 2Edge SB, Byrd DR, Edge SB, et al. Exocrine and endocrine pancreas. In: AJCC Cancer Staging Manual. 7th ed[J]. Phila- delphia: Springer, 2010:241-249.
  • 3Halfdanarson TR, Rabe KG, RubinJ, et al. Pancreatic neu?roendocrine tumors (PNETs) : incidence, prognosis and recent trend toward improved survival[J]' Ann Oncol , 2008,19: 1727-1733.
  • 4White TJ, EdneyJA, ThompsonJS, et al. Is there a prognos?tic difference between functional and nonfunctional islet cell tumors?[J]. AmJ Surg, 1994,168:627-630.
  • 5SarmientoJM, Farnell MB, Que FG, et al. Pancreaticoduode?nectomy for islet cell tumors of the head of the pancreas: long?term survival analysis[J]. WorldJ Surg, 2002,26:1267-1271.
  • 6Phan GQ, Yeo CJ, Hruban RH, et al. Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: re?view of 125 patients[J]'J Gastrointest Surg, 1998, 2: 473-482.
  • 7Williams ED, Siebenmann, RE, Sobin LH, et al. International histological classification of tumours: Histological typing of en?docrine tumours[M]. Geneva: WHO press, 1980: 19-22.
  • 8Hamilton SR, Aaltonen LA. World Health Organization clas?sification of turnours. Pathology and genetics of tumours of the digestive system[MJ. Lyon: LARC Press, 2000: 53-54.
  • 9Bosman FT, Carneiro F, Hruban RH, et al. Pathology and genetics of tumours of the digestive system[M]. Lyon: IARC press, 2010: 13-14.
  • 10Ellison TA, Wolfgang CL, Shi C, et al. A Single institutions 26-year experience with nonfunctional pancreatic neuroendo?crine tumors: a validation of current staging systems and a new prognostic nomogram[J]' Ann Surg, 2013, 249: 721-723.

二级参考文献19

  • 1张太平,赵玉沛,朱预,蔡力行,崔全才,陈杰.无功能胰岛细胞瘤的临床病理特点与外科治疗[J].中华医学杂志,2005,85(37):2647-2650. 被引量:15
  • 2Hidalgo M. Pancreatic cancer[J]. N Engl J Med, 2010, 362: 1605-1617.
  • 3Velasco JM, Rossi H, Hieken TJ, et al. Laparoscopic ultra sound enhances diagnostic laparoseopy in the staging of in traabdominal neoplasms[J]. Am Surg, 2000, 66:407-411.
  • 4John TG, Wright A, Allan PL, et al. Laparoscopy with laparoscopic ultrasonography in the TNM staging of pancreatic carcinoma[J]. World J Surg, 1999, 23:870-881.
  • 5Kliment M, Urban O, Cegan M, et al. Endoscopic ultra sound guided fine needle aspiration of pancreatic masses: the utility and impact on management of patients[J]. Scand J Gastroenterol, 2010, 45:1372-1379.
  • 6Fisher L, Segarajasingam DS, Stewart C, et al. Endoscopic ultrasound guided fine needle aspiration of solid pancreatic lesions:performance and outcomes[J]. J Gastroenterol Hepatol, 2009, 24:90-96.
  • 7Conlon KC, Dougherty E, Klimstra DS, et al. The value of minimal access surgery in the staging of patients with potentially respectable peripancreatic malignancy [J]. Ann Surg, 1996, 223:134-140.
  • 8Yeo CJ, Cameron JL, Sohn TA, et al. Pancreaticoduodenec tomy with or without extented retro-peritoneal lymphadenectomy for periampullary adenocarcinoma:comparison of morbidity and mortality and short-term outeome[J]. Ann Surg, 1999, 229:613-622.
  • 9Farnell MB, Pearson RK, Sarr MG, et al. A prospective ran domized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma[J]. Surgery, 2005, 138:618-630.
  • 10Riall TS, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma-part 3:update on 5-year survival[J]. J Gastrointest Surg, 2005, 9:1191-1204.

共引文献15

同被引文献143

  • 1张嘉炜,孟翔凌,吴文涌,王德志.胰腺内分泌肿瘤的诊断及手术治疗[J].山东医药,2010,50(50):53-54. 被引量:4
  • 2何天霖,胡先贵,张怡杰,刘瑞,邵成浩.胰腺神经内分泌肿瘤的外科诊治[J].中华普通外科杂志,2007,22(7):494-496. 被引量:3
  • 3TR H, Rubin J, MB F. Pancreatic endocrine neoplasms:epidemi- ology and prognosis of pancreatic endocrine tumors [ [ J ]. Endocr Relat Canner, 2008(15) :409-427.
  • 4Yao JC, Eisner MP, Leay C, et al. Population-based study of islet cell carcinoma [ J ]. Ann Surg Oncol, 2007 ( 14 ) : 3492-3500.
  • 5Demirkan BH, Eriksson B. Systemic treatment of neuroendocrine tumors with hepatic metastases [ J]. Turk J Gastroenterol, 2012 ( 23 ) :427-437.
  • 6Capurso G, Bettini R, Rinzivillo M, et al. Role of resection of the primary pancreatic neuroendocrine tumor only in patients with unr- esectable metastatic liver disease: a systemic review [ J ]. Neuroendocrinology, 2011 ( 93 ) :225-227.
  • 7Eriksson J, Stalberg P, Nilsson A, et al. Surgery and radiofre- queney ablation for treatment of liver metastasis from midgut and foregut careinoid and endocrine pancreatic tumors [ J ]. World J Surg, 2008(38) :930-938.
  • 8WMichalski C, Erkan M, Huser N, et al. Resection of primary pancreatic cancer and liver metastatic : a systematic review [ J ]. Digestive surgery, 2008 ( 25 ) :475-479.
  • 9Skye C, Mechteld C, Mark B, et al. Surgery versus intra arterial therapy for neuroendocrine liver metastasis : a multicenter interna- tional analysis [ J ]. Ann Surg Oncol, 2011 ( 18 ) : 3657 -3665.
  • 10Cusati D, Zhang L, Harmsen WS, etal. Metastatic norrfunctianing pancreatic neuroendocfine carcinoma to liver: surgieal treatment and outcomes[J]. J Am Coil Surg, 2012(215) :119-120.

引证文献12

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部